Addex Therapeutics Ltd - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ADXN Nasdaq 2836 www.addextherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Addex Therapeutics Ltd

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Nov 22nd, 2024 6:00 am
Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024 - Nov 11th, 2024 6:00 am
Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update - Sep 30th, 2024 5:00 am
Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit - Sep 19th, 2024 5:00 am
Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Sep 4th, 2024 5:00 am
Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration - Aug 27th, 2024 5:00 am
Addex’s Partner Discontinues ADX71149 development in Epilepsy - Jul 22nd, 2024 5:00 am
Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS) - Jul 15th, 2024 5:00 am
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS) - Jul 12th, 2024 5:00 am
Addex Shareholders Approve All Resolutions at Annual General Meeting - Jul 1st, 2024 5:00 am
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update - Jun 6th, 2024 5:00 am
Addex Convenes Annual General Meeting 2024 - Jun 5th, 2024 5:00 am
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024 - May 31st, 2024 5:00 am
Addex to Present at Bio€quity Europe 2024 - May 8th, 2024 5:00 am
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study - Apr 29th, 2024 5:00 am
Addex to Present at the Swiss Biotech Day 2024 - Apr 19th, 2024 5:00 am
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update - Apr 18th, 2024 5:00 am
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024 - Apr 11th, 2024 5:00 am
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders - Apr 3rd, 2024 5:00 am
Addex to Present at the Bio-Europe Spring 2024 Conference - Mar 14th, 2024 6:00 am